Amgen, Zhejiang Beta Pharma Form Joint Venture

Source: PharmaManufacturing.com

May 13, 2013

FOX Business

Amgen Inc. (AMGN) will form a joint venture with Chinese pharmaceutical firm Zhejiang Beta Pharma Co. to bring its colon cancer drug Vectibix to the Chinese market.

Zhejiang Beta Pharma will own 51% and Amgen will own the remaining 49% interest in the joint venture, to be named Amgen-Beta Pharmaceuticals Co., the companies said. Read the full story

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments